| 51 |
24022933 | [Effect of Oxaliplatin on cell cycle of hepatocellular carcinoma cell line HepG2]. | 2013 Jul |
1 |
| 52 |
24118195 | Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells. | 2013 Dec |
1 |
| 53 |
22678405 | The different induction mechanisms of growth arrest DNA damage inducible gene 45 β in human hepatoma cell lines. | 2012 |
2 |
| 54 |
23066038 | A novel evolutionarily conserved element is a general transcriptional repressor of p21WAF¹/CIP¹. | 2012 Dec 1 |
1 |
| 55 |
23192191 | Studies on the interaction mechanism of pyrene derivatives with human tumor-related DNA. | 2012 Nov 28 |
3 |
| 56 |
20734047 | Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance. | 2011 Jun |
1 |
| 57 |
20839263 | Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. | 2011 Jul 15 |
5 |
| 58 |
20980256 | The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. | 2011 Jan 7 |
2 |
| 59 |
20980803 | Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death. | 2011 Jan 1 |
1 |
| 60 |
21508389 | Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer. | 2011 Apr |
1 |
| 61 |
21623005 | Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. | 2011 May |
2 |
| 62 |
21628572 | Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis. | 2011 Jun 28 |
3 |
| 63 |
19728331 | Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. | 2010 Apr 1 |
1 |
| 64 |
19833818 | Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. | 2010 Apr |
2 |
| 65 |
20128802 | Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors. | 2010 Mar |
3 |
| 66 |
20354524 | Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa. | 2010 Apr 13 |
2 |
| 67 |
20708607 | Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells. | 2010 Dec 5 |
4 |
| 68 |
19015155 | Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. | 2009 Jan |
4 |
| 69 |
19247656 | Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. | 2009 Oct |
2 |
| 70 |
19266094 | The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. | 2009 |
5 |
| 71 |
19328230 | Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation. | 2009 Jun 15 |
1 |
| 72 |
19581934 | Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells. | 2009 Sep 3 |
5 |
| 73 |
19723892 | Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells. | 2009 Sep |
1 |
| 74 |
19735649 | Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells. | 2009 Dec 10 |
7 |
| 75 |
18345033 | P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells. | 2008 Jul 10 |
6 |
| 76 |
18508032 | Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines. | 2008 Jul 1 |
1 |
| 77 |
17237273 | The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells. | 2007 Jan |
1 |
| 78 |
17343830 | Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines. | 2007 Jun 1 |
2 |
| 79 |
17559811 | p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells. | 2007 Aug 1 |
8 |
| 80 |
18025273 | Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. | 2007 Nov |
2 |
| 81 |
17045763 | Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells. | 2006 Dec 1 |
9 |
| 82 |
16204068 | Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer. | 2005 Oct 1 |
2 |
| 83 |
16227409 | Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. | 2005 Oct |
3 |
| 84 |
14985457 | Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect. | 2004 Feb |
3 |
| 85 |
15041737 | Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. | 2004 Mar 15 |
6 |
| 86 |
15334062 | Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. | 2004 Sep 30 |
1 |
| 87 |
15545975 | Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. | 2004 Nov 29 |
1 |
| 88 |
12570658 | Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair. | 2003 Feb |
1 |
| 89 |
12684687 | The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. | 2003 May |
1 |
| 90 |
12499281 | Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. | 2002 Dec 15 |
2 |